call 1800 257 600 email [email protected]

Clinical Trials

Cancer Type

State

Phase

Treatment

Inhibitor

A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

NCT 06351904 Brief Summary This is an open label, multi-center study…

Read more arrow_forward

A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) (LIBRETTO-001)

NCT 03157128 Brief Summary This is an open-label, first-in-human study designed to…

Read more arrow_forward

A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors

NCT 06063681 Brief Summary This is an open-label, dose-escalation, multi-center phase 1…

Read more arrow_forward

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ATG 037 Monotherapy and Combination Therapy With Pembrolizumab in Patients With Advanced Solid Tumors

NCT 05205109 Brief Summary This is a study of ATG-037 Monotherapy and…

Read more arrow_forward

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

NCT 04913285 Brief Summary The purpose of this study is to evaluate…

Read more arrow_forward

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) (IMCODE004)

NCT 06534983 Brief Summary The main purpose of the study is to…

Read more arrow_forward

A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) (IMCODE004)

NCT 06534983 Brief Summary The main purpose of the study is to…

Read more arrow_forward

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT 05487235 Brief Summary The purpose of this study is to evaluate…

Read more arrow_forward

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-6036 Alone or in Combination in Participants With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation

NCT 04449874 Brief Summary This is a Phase I dose-escalation and dose-expansion…

Read more arrow_forward

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT 05581004 Brief Summary This is a first-in-human study to evaluate the…

Read more arrow_forward

Knowledge Base

Cancer Types Cancer Services Health Professionals Clinical Trials

How we help you

Our support knows no limits, which means we do whatever it takes to be there for all you need.

How we help you View the Rare Cancer Support Guide

Can’t find what you’re looking for?

We have a friendly team available to chat about any questions you may have, or just to lend an ear if you’re having a tough time.

Call 1800 257 600 Have us call you